84688-83-5

Upstream product

• 1973-09-7 6-chloro-N,N'-diphenyl-1,3,5-triazine-2,4-diamine 
• 99-92-3 p-aminobenzophenone 
• 2272-40-4 2-phenylamino-4,6-dichloro-s-triazine 
• 62-53-3 aniline 

Downstream Products

• 1062320-02-8 2,4-bis-(phenylamino)-6-[4'-{3''-(2'''-methoxyphenyl)-1''-oxo-2''-propen-1''-yl}-phenylamino]-s-triazine 
• 1215208-28-8 C₂₈H₂₂N₆O₂ 
• 1215208-29-9 C₂₈H₂₂N₆OS 
• 1254838-66-8 2,4-bis(phenylamino)-6-[4'-{2''-(4'''-fluorophenyl)-2'',3''-dihydro-1'',5''-benzothiazepine-4''-yl}phenylamino]-s-triazine 
• 1254838-67-9 2,4-bis(phenylamino)-6-[4'-{2''-(4'''-N,N-dimethylaminophenyl)-2'',3''-dihydro-1'',5''-benzothiazepine-4''-yl}phenylamino]-s-triazine 
• 1254838-68-0 2,4-bis(phenylamino)-6-[4'-{2''-(4'''-N,N-diethylaminophenyl)-2'',3''-dihydro-1'',5''-benzothiazepine-4''-yl}phenylamino]-s-triazine 
• 1254838-70-4 2,4-bis(phenylamino)-6-[4'-{2''-(2-furanyl)-2'',3''-dihydro-1'',5''-benzothiazepine-4''-yl}phenylamino]-s-triazine 
• 1254838-71-5 2,4-bis(phenylamino)-6-[4'-{2''-(2-thienyl)-2'',3''-dihydro-1'',5''-benzothiazepine-4''-yl}phenylamino]-s-triazine 
• 1254838-72-6 2,4-bis(phenylamino)-6-[4'-{5''-(4-fluorophenyl)-2''-isoxazol-3''-yl}phenylamino]-s-triazine 
• 1254838-73-7 2,4-bis(phenylamino)-6-[4'-{5''-(4-N,N-dimethylaminophenyl)-2''-isoxazol-3''-yl}phenylamino]-s-triazine 
• 1254838-76-0 2,4-bis(phenylamino)-6-[4'-{5''-(2-furanyl)-2''-isoxazol-3''-yl}phenylamino]-s-triazine 
• 1254838-77-1 2,4-bis(phenylamino)-6-[4'-{5''-(2-thienyl)-2''-isoxazol-3''-yl}phenylamino]-s-triazine 
• 1207960-98-2 C₃₉H₃₅N₇O₂ 

Relevant academic research and scientific papers

Experimental and quantum chemical studies of synthesized triazine derivatives as an efficient corrosion inhibitor for N80 steel in acidic medium

Corrosion inhibition of N80 steel in a 15% HCl solution was studied using two synthesized triazine derivatives, namely: N2-(4-(2-amino-6-(4-methoxyphenyl)pyrimidine-4-yl)phenyl)-N4,N6-diphenyl-1,3,5-triazine-2,4,6-triamine

Synthesis and characterization of s-triazine based 1,5-benzothiazepines and isoxazoles

Series of compounds 2,4-bis-phenylamino-6-[4′-{2″-(substituted phenyl/cinnamyl/2?-furanyl/2?-thicnyl)-2″, 3″-dihydro-1″,5″-benzothiazepine-4″-yl}phenyl amino]-s-triazine 7(a-f) were prepared by reaction of different chalcones and 2-amino thiophenol in the

Synthesis of some new S-triazine based chalcones and their derivatives as potent antimicrobial agents

Base catalysed condensation of ketone 5 with different aldehydes give chalcones, 2.4-bis-(phenylamino)-6-[4′-{3″-(4?-substituted phenyl/2?-furanyl/2?-thienyl)-2″-propenon-1″-y l}phenylamino]-s-thriazines 6a-e. These chalcones on cyclization with hydrazine

Synthesis and antibacterial evaluation of s-triazine based chalcones and their derivatives

Various 2-(phenylamino/4′-substituted phenylamino)-4-(phenylainino/ 4′-substituted phenylamino)-6-[4′-{3″-(4?-{2′- (5′-ethylpyridin-2′-yl)-ethoxy}-phenyl)-2″-propenon-1″- yl}-phenylamino]-s-triazine 6(a-e) were prepared by reaction of different ketones 5(

Synthesis and characterization of some novel isoxazoles and 1,5-benzothiazepines bearing 5-triazine nucleus

The title compounds 7a-d and 8a-d have been prepared starting from chalcones 6a-d having i-triazine nucleus. These chalcones 6a-d on cyclisation with hydroxylamine hydrochloride in presence of alkali and 2-aminothiophenol in presence of a few drops of gla

Synthesis and studies of some novel s-triazine based aminopyrimidines, isoxazoles and 1,5-benzothiazepines

An elegant synthesis of the titled compounds 7a-e, 8a-e and 9a-e have been presented starting from chalcones 6a-e based on s-triazine nucleus. These chalcones 6a-e on cyclisation with guanidine nitrate and hydroxylamine hydrochloride in the presence of al

2,4,6-TRIAMINO-1,3,5-TRIAZINE DERIVATIVE

This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned. Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder. Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action.